Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

24,279 signal articles · 44 in last 24h · 115,444 total before filter · latest 1h ago
44last 24h
1767last 7d
297● bullish (7d)
170● bearish (7d)
205publishers
AllMacro315Earnings818M&A103Regulatory25Product16Analyst26
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Johnson & Johnson beats Q2 estimates, raises full-year 2026 guidance
Proactive31d agobullish
Johnson & Johnson beats Q2 estimates, raises full-year 2026 guidance

Johnson & Johnson (NYSE:JNJ) reported better-than-expected second quarter results and raised its full-year 2026 outlook, as strong pharmaceutical sales helped offset headwinds from products facing patent competition. The healthcare company posted adjusted earnings per share of $2.90 for...

Morgan Stanley Q2 Earnings Call Highlights
MarketBeat31d agoneutral
Morgan Stanley Q2 Earnings Call Highlights

Morgan Stanley (NYSE:MS) reported record second-quarter 2026 results, with executives citing strong client activity across institutional securities, wealth management and investment management, as well as continued benefits from the firm’s integrated business model. Chairman and Chief Executive Off

Johnson & Johnson Q2 Earnings Call Highlights
MarketBeat31d agoneutral
Johnson & Johnson Q2 Earnings Call Highlights

Johnson & Johnson (NYSE:JNJ) raised its full-year 2026 outlook after reporting second-quarter sales growth that management said was supported by strength in Innovative Medicine, new product launches and a broad portfolio that helped offset continued pressure from STELARA biosimilar competition.